Literature DB >> 16287144

The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations.

Gideon Bach1, Michael B T Webb, Ruth Bargal, Marcia Zeigler, Joseph Ekstein.   

Abstract

Mucolipidosis type IV (MLIV) is a neurodegenerative lysosomal storage disorder that occurs in an increased frequency in the Ashkenazi Jewish (AJ) population. The frequency of the disease in this population has been established by the testing of 66,749 AJ subjects in the Dor Yeshorim program, a unique premarital population-screening program designed for the Orthodox Jewish community. A carrier rate of 0.0104 (95% C.I 0.0097-0.011) was found. The distribution of the 2 AJ founder mutations, namely, c.416-2A>G and c.1_788del, was determined to be 78.15% and 21.85%, respectively. Three novel mutations were identified in non-Jewish MLIV patients, a missense mutation c.1207C>T, p.Arg403Cys; a 2bp deletion, c.302_303delTC; and a nonsense, c.235C>T, Gln79X. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287144     DOI: 10.1002/humu.9385

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

1.  A novel homozygous MCOLN1 double mutant allele leading to TRP channel domain ablation underlies Mucolipidosis IV in an Italian Child.

Authors:  Marisol Mirabelli-Badenier; Mariasavina Severino; Barbara Tappino; Domenico Tortora; Francesca Camia; Clelia Zanaboni; Fabia Brera; Enrico Priolo; Andrea Rossi; Roberta Biancheri; Maja Di Rocco; Mirella Filocamo
Journal:  Metab Brain Dis       Date:  2014-08-26       Impact factor: 3.584

Review 2.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

3.  Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.

Authors:  Stuart A Scott; Lisa Edelmann; Liu Liu; Minjie Luo; Robert J Desnick; Ruth Kornreich
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

Review 4.  TRP channels and Ca2+ signaling.

Authors:  Baruch Minke
Journal:  Cell Calcium       Date:  2006-06-27       Impact factor: 6.817

5.  Mucolipidosis type IV: a subtle pediatric neurodegenerative disorder.

Authors:  Joseph S Geer; Steve A Skinner; Ehud Goldin; Kenton R Holden
Journal:  Pediatr Neurol       Date:  2010-03       Impact factor: 3.372

6.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

Review 7.  Current concepts in the neuropathogenesis of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Steven U Walkley
Journal:  J Neurochem       Date:  2018-08-30       Impact factor: 5.372

8.  Codeficiency of Lysosomal Mucolipins 3 and 1 in Cochlear Hair Cells Diminishes Outer Hair Cell Longevity and Accelerates Age-Related Hearing Loss.

Authors:  Teerawat Wiwatpanit; Natalie N Remis; Aisha Ahmad; Yingjie Zhou; John C Clancy; Mary Ann Cheatham; Jaime García-Añoveros
Journal:  J Neurosci       Date:  2018-02-16       Impact factor: 6.167

9.  Systematic screens for proteins that interact with the mucolipidosis type IV protein TRPML1.

Authors:  Ellen Spooner; Brooke M McLaughlin; Talya Lepow; Tyler A Durns; Justin Randall; Cameron Upchurch; Katherine Miller; Erin M Campbell; Hanna Fares
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 10.  Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.

Authors:  L D Osellame; M R Duchen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.